Psychopharmacology

A single dose of caffeine and L-theanine may help teens with ADHD ignore distractions. Recent brainwave data indicates this nutritional combination enhances the brain's ability to process visual information and prevents attention from fading over time.

A new study reveals that daily doses of psilocin mucate, a stable derivative of the psychedelic compound psilocybin, significantly reduced anxiety and stress hormones in rats. However, weekly dosing did not produce the same anti-anxiety benefits.

Testing how a patient responds to a single dose of stimulant medication might help doctors predict treatment success. Researchers found that early behavioral changes can accurately forecast long-term symptom relief in adults with ADHD.

A ketogenic diet could surprisingly alter the body's relationship with alcohol. New research in rats indicates that switching to a high-fat diet slows down liver metabolism, spiking blood alcohol levels while simultaneously curbing the urge to drink.

A recently developed psychedelic compound promotes brain plasticity and reduces anxiety in mice without triggering gastrointestinal distress. The findings provide a chemical blueprint for designing safer, more tolerable psychiatric treatments.

New research indicates that adults who frequently consume cannabis have higher baseline cortisol levels immediately upon waking. Interestingly, this elevated morning stress hormone is closely linked to experiencing negative life consequences from cannabis use.

A new study indicates that introverts and individuals with lower natural joy experience the greatest mood boosts from dopamine-altering drugs and antidepressant placebos. The findings suggest that baseline personality heavily influences how people respond to mood treatments.

A new clinical trial suggests that a single day of treatment with the inhaled psychedelic mebufotenin can rapidly relieve severe symptoms of postpartum depression, offering a potential alternative to daily medications.

A new study reveals that regularly employed patients are more likely to drop out of outpatient alcohol treatment than those without steady jobs, suggesting standard clinic hours create hidden barriers to addiction recovery.

Anorexia nervosa is notoriously difficult to treat, often resisting standard care. Now, a new pilot study suggests that psilocybin therapy, paired with psychological support, could safely help reduce eating disorder symptoms and boost the motivation to recover.

A large study tracking thousands of adults over five years reveals that core personality traits, particularly extraversion and conscientiousness, strongly predict how often a person drinks alcohol.

New research indicates that psilocybin treatment for PTSD involves very little talking. Instead of traditional psychotherapy, data suggests patients benefit most from the quiet, unobtrusive presence of support staff.

Stopping the common ADHD medication methylphenidate may cause lasting sleep disruptions. A new animal study reveals that rats experience fragmented rest and altered circadian rhythms ten days after ceasing the drug, highlighting potential long-term withdrawal effects.

A common ADHD medication helps children focus by stabilizing how different regions of the brain communicate, reducing the rapid shifts in neural connections that often lead to distraction.

A new study indicates that brief experiences with inhaled DMT can reduce anxiety and improve life satisfaction. For patients with treatment-resistant depression, the substance combined with therapy might promote long-lasting enhancements in overall quality of life.